Loss of white adipose hyperplastic potential is associated with enhanced susceptibility to insulin resistance.
about
Adipose tissue plasticity: how fat depots respond differently to pathophysiological cuesAging and adipose tissue: potential interventions for diabetes and regenerative medicineImmunological contributions to adipose tissue homeostasisAmplification of Adipogenic Commitment by VSTM2AMetabolism Disrupting Chemicals and Metabolic DisordersEffect of lipopolysaccharides on adipogenic potential and premature senescence of adipocyte progenitors.Exercise-Induced Skeletal Muscle Adaptations Alter the Activity of Adipose Progenitor CellsEffects of low-fat diet and aging on metabolic profiles of Creb3l4 knockout mice.Tenomodulin promotes human adipocyte differentiation and beneficial visceral adipose tissue expansion.Obesogens: an emerging threat to public health.Adipose tissue fibrosis, hypertrophy, and hyperplasia: Correlations with diabetes in human obesity.Sorting out adipocyte precursors and their role in physiology and diseaseOverexpressing the novel autocrine/endocrine adipokine WISP2 induces hyperplasia of the heart, white and brown adipose tissues and prevents insulin resistanceImaging mass spectrometry demonstrates age-related decline in human adipose plasticity.Maternal obesity epigenetically alters visceral fat progenitor cell properties in male offspring mice.Identification of Mouse Mesenteric and Subcutaneous in vitro Adipogenic Cells.Multiethnic genome-wide meta-analysis of ectopic fat depots identifies loci associated with adipocyte development and differentiation.Adipocyte hypertrophy-hyperplasia balance contributes to weight loss after bariatric surgery.Inhibition of adipose tissue PPARγ prevents increased adipocyte expansion after lipectomy and exacerbates a glucose-intolerant phenotype.The expanding problem of adipose depot remodeling and postnatal adipocyte progenitor recruitment.Depot specific differences in the adipogenic potential of precursors are mediated by collagenous extracellular matrix and Flotillin 2 dependent signalingAdipose tissue: between the extremes.Targeting FOXO1 as an option to treat obesity?Induction of adipose and hepatic SWELL1 expression is required for maintaining systemic insulin-sensitivity in obesity.Chronic High Dose Zinc Supplementation Induces Visceral Adipose Tissue Hypertrophy without Altering Body Weight in Mice.PDGFRα/PDGFRβ signaling balance modulates progenitor cell differentiation into white and beige adipocytes.Quantitative imaging of deuterated metabolic tracers in biological tissues with nanoscale secondary ion mass spectrometry.Obesity phenotypes: depot-differences in adipose tissue and their clinical implications.Causes and mechanisms of adipocyte enlargement and adipose expansion.BET bromodomain proteins regulate enhancer function during adipogenesis.Parallels in Immunometabolic Adipose Tissue Dysfunction with Ageing and Obesity.Two paths to fat.Adipose Tissue Function and Expandability as Determinants of Lipotoxicity and the Metabolic Syndrome.De novo adipocyte differentiation from Pdgfrβ+ preadipocytes protects against pathologic visceral adipose expansion in obesity.Abdominal subcutaneous and visceral adipocyte size, lipolysis and inflammation relate to insulin resistance in male obese humans.Chemerin: a multifaceted adipokine involved in metabolic disorders.Cytometric analysis of adipose tissue reveals increments of adipocyte progenitor cells after weight loss induced by bariatric surgery-Limonene Enhances Differentiation and 2-Deoxy-D-Glucose Uptake in 3T3-L1 Preadipocytes by Activating the Akt Signaling PathwayIdentification of functionally distinct fibro-inflammatory and adipogenic stromal subpopulations in visceral adipose tissue of adult mice
P2860
Q26753066-1BCE4C0F-2743-4825-92D1-8A1359E31EE7Q28079178-10148744-E2C3-424D-9740-42266B91E736Q28084995-502D455D-B877-4BD9-A8F8-AC34FF9FD0FDQ28854368-5FCA388B-5792-4116-A55A-EC0A0C454EECQ29248099-C08B6BE3-1159-4393-98F1-4DAA935B2584Q35958518-76300FCC-9FEC-4EC1-80D2-C742C8DA7389Q35970418-FEC5EC20-1868-4A38-A8E2-30A16608A72DQ36022458-8F3F48FC-DDE6-4C6A-AB31-46E53716038FQ36591198-EC677409-D3E5-4C88-992B-271CE44E0277Q36853195-47843058-5563-448A-A758-5A12FC0F6D3FQ37036130-0301EB55-AC50-43BC-9944-62EF8389B304Q37661668-554ED151-01AD-45E0-8982-F4EC67E70724Q37668148-008ABE60-E44F-4BB5-8670-87AD8A79DA7AQ37677435-A1203C7E-D651-405B-BF47-6A94347B4968Q38292919-C5511737-5B33-4095-8875-191E16AD89EDQ38529083-39C07F9D-CAAC-434F-B312-7935D7C46641Q38787114-D32E397E-549E-450D-8FCC-6984C48F82C9Q38829061-47B08D1E-E46A-4E90-997F-247E1CA2D40AQ39099668-CAEF5B81-3473-4682-810F-0DB175B75A7CQ39288232-B914F58C-7B3E-4DA3-8EBC-848BD11C3D6DQ39335370-956C645B-847E-4E99-B456-FCD30413601BQ39379288-A518C243-DC5C-439D-9AF0-AD2A8910F330Q41911044-3AA70D40-42D2-40DF-832B-8A6FFEAAB06DQ41942020-B3445153-399E-401E-B091-66ECA37810C1Q47151139-199C42E1-3390-44F0-B381-F08D80AAD707Q47284167-F753A903-5F24-41A8-A3CD-E3F7F733CEA8Q47741842-88E4B699-4D66-4AC9-8F30-B4409C1070FDQ48136666-2A70B7CB-EFA0-49C2-AC94-98B18470480FQ49832016-1BE7E636-79C9-49D4-A043-56D12079AAE5Q50042268-FCBA32C9-6230-464B-A540-2B6460D1A3CAQ51767342-76F2AF0B-523B-4EC5-BB45-8D480D036993Q52955984-59BF0478-7599-43DC-8154-81191657A2DDQ53737668-1072E99C-DAF5-4A2B-A33C-7EC9BEE6E5F4Q54123539-C7EC5B3D-0059-44BE-AC03-B18E78B60150Q55030703-6375FF7B-37FC-456A-B4C6-0751CC4AA286Q55435289-16F7A655-24D0-485D-9DDF-14DF6E3876AAQ57472607-859FC7A2-267F-4EF0-B6A4-B5DC684DA136Q58766921-24EAF50B-EA2F-4E8F-8B48-0444FB91E304Q59125876-10B94749-3943-4419-84CB-647C2C2F0D66
P2860
Loss of white adipose hyperplastic potential is associated with enhanced susceptibility to insulin resistance.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Loss of white adipose hyperpla ...... ibility to insulin resistance.
@ast
Loss of white adipose hyperpla ...... ibility to insulin resistance.
@en
type
label
Loss of white adipose hyperpla ...... ibility to insulin resistance.
@ast
Loss of white adipose hyperpla ...... ibility to insulin resistance.
@en
prefLabel
Loss of white adipose hyperpla ...... ibility to insulin resistance.
@ast
Loss of white adipose hyperpla ...... ibility to insulin resistance.
@en
P2093
P2860
P1433
P1476
Loss of white adipose hyperpla ...... ibility to insulin resistance.
@en
P2093
Christelle Guillermier
Matthew L Steinhauser
Mingyue Lun
Parth Patwari
Samuel E Senyo
P2860
P304
P356
10.1016/J.CMET.2014.10.010
P577
2014-11-20T00:00:00Z